BioHealth News Archive
JHTV Contracts Team Finds Extra Meaning in Supporting Researchers’ COVID-19 Work | Johns Hopkins Technology Ventures
Virologist Andrew Pekosz has a team of 15 people working around the clock in his lab at the Johns Hopkins Bloomberg School of Public…
Read More
BioFactura, Inc. Co-Founder, President & CEO, Darryl Sampey, PH.D., Virtually Sits Down with Rich Bendis for BioTalk
BioFactura, Inc. Co-Founder, President & CEO, Darryl Sampey, PH.D., joins BioTalk to discuss his background with the University of Maryland, the BioHealth Capital Region,…
Read More
KidneyX Summit Announces Winners of the Redesign Dialysis Phase 2 Prize | Kidney News
Today, July 22nd, a virtual summit was hosted by KidneyX to announce the six winners of the Redesign Dialysis Phase 2 prize. The goal…
Read More
Vita Therapeutics receives Orphan Drug Designation from FDA for new novel treatment
BALTIMORE, July 23, 2020 /PRNewswire/ -- Vita Therapeutics, Inc. announced today that it received orphan drug designation (ODD) from the U.S. Food and Drug Administration…
Read More
D.C. imposes self-quarantine for travelers from 27 states – Washington Business Journal
D.C. is requiring people making travel into Washington from 27 states to self-quarantine because of new surges in Covid-19 cases. The order went into…
Read More
Leading through Change and Resilency Classes Available Through MC
Montgomery College announces several pop-up, remote classes which could be valuable for you and your teams: : Sustaining Resilience MGT632 (crn#16869), August 5, 2020, …
Read More
Creatv MicroTech Aims to Detect Patient Immune Cells for Cancer Drug Response Prediction
NEW YORK – Liquid biopsy firm Creatv MicroTech is developing a diagnostic platform that measures the amount and size of specific circulating stromal cells called…
Read More
AstraZeneca, U. of Oxford Report Positive Phase I/II Data for COVID-19 Vaccine Candidate
Researchers from AstraZeneca, the University of Oxford, and its spinout company Vaccitech today published preliminary Phase I/II data showing their closely-watched COVID-19 vaccine candidate…
Read More
5 Questions with Sara Nayeem, M.D., a Partner at New Enterprise Associates (NEA) · BioBuzz
“5 Questions With……” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read More
citybizlist : Washington DC : “COVID-19-Edition” of Pediatric Medical Device Competition Announces Finalists
Sixteen finalists are announced in the "Make Your Medical Device Pitch for Kids!” special COVID-19 edition competition presented by the National Capital Consortium for…
Read More
Eight Drivers that Will Define Digital Health in the 2020s | by Robert Lord | LionBird | Jul, 2020 | Medium
As we embark on our third fund at LionBird, we believe that proactively thinking deeply about what will drive the next decade of healthcare…
Read More
These 6 pandemic response apps won the University System of Maryland’s COVID App Challenge – Technical.ly Baltimore
Facial temperature detection, campus heatmaps: They’re among the tools in a collection of apps created by teams from within the University System of Maryland over…
Read More
Altimmune making headway with Covid-19 programs – Washington Business Journal
Altimmune Inc. is making progress on its Covid-19 vaccine more than four months after jumping into that arena. The Gaithersburg biopharma said Monday it…
Read More
Life-Science Real Estate Booming Amid Pandemic – The Real Deal
The search for a cure for Covid-19 is lining the pockets of some landlords. While the pandemic wreaks financial havoc on hotels and retailers,…
Read More
BARDA upgrades Emergent pact with $258M option for anthrax vaccine stores | FiercePharma
Drugmakers around the world are scrambling to develop a COVID-19 shot, and Emergent BioSolutions has already signed on to help produce doses for some…
Read More